Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), continues to spread around the world. While prophylactic vaccines against SARS-CoV-2 are making great progress, there is still a need to explore safe and effective therapies with biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenghai, Zhao, Hua, Cheng, Linna, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018429/
https://www.ncbi.nlm.nih.gov/pubmed/33824579
http://dx.doi.org/10.2147/DDDT.S301173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018429/
https://www.ncbi.nlm.nih.gov/pubmed/33824579
http://dx.doi.org/10.2147/DDDT.S301173

Ejemplares similares